Published in
Elsevier, American Heart Journal, (225), p. 69-77, 2020
DOI: 10.1016/j.ahj.2020.03.018
Links
Tools
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
Journal article published in 2020 by
Ganesan Karthikeyan 
,
Stuart J. Connolly,
Mpiko Ntsekhe,
Alexander Benz,
Sumathy Rangarajan,
Gayle Lewis,
Yan Yun,
Sanjib Kumar Sharma,
Fathi Maklady,
Alaa Eldin Elghamrawy,
Khawar Kazmi,
Tantchou T. J. Cabral,
Hu Dayi,
Ma Changsheng,
Bernard M. Gitura
and other authors.
,
Stuart J. Connolly,
Mpiko Ntsekhe,
Alexander Benz,
Sumathy Rangarajan,
Gayle Lewis,
Yan Yun,
Sanjib Kumar Sharma,
Fathi Maklady,
Alaa Eldin Elghamrawy,
Khawar Kazmi,
Tantchou T. J. Cabral,
Hu Dayi,
Ma Changsheng,
Bernard M. Gitura
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 